alphavePFIZER₹4,092.00

Pfizer Ltd.

₹ CrorePeersGLAXO ABBOTINDIA POLYMED ONESOURCE RAINBOW KIMS JUBLPHARMA VIJAYA

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	151.0	171.8	136.1	136.1
+ Capital Work-in-Progress	0.4	7.6	20.0	20.0
+ Goodwill	527.5	527.5	527.5	527.5
+ Other Intangibles	34.3	24.3	14.4	14.4
+ Other Non-current Financial Assets	14.3	13.9	15.2	15.2
+ Deferred Tax Assets	53.9	69.3	72.3	72.3
+ Other Non-current Assets	213.7	166.5	—	—
Total Non-current Assets	1,459.2	1,398.3	1,118.7	1,118.7
Current Assets
+ Inventories	433.7	475.9	472.7	472.7
+ Trade Receivables	187.6	193.1	181.8	181.8
+ Cash & Cash Equivalents	112.0	495.1	102.7	102.7
+ Other Bank Balances	1,934.7	2,305.9	3,008.1	3,008.1
+ Other Current Financial Assets	13.0	3.9	3.0	3.0
Current Financial Assets	2,247.3	2,998.0	3,295.5	3,295.5
+ Other Current Assets	56.8	39.0	35.0	35.0
Total Current Assets	2,737.8	3,512.9	3,803.2	3,803.2
Total Assets	4,228.8	4,911.1	4,921.9	4,921.9
Equity
+ Equity Share Capital	45.8	45.8	45.8	45.8
+ Other Equity / Reserves	3,549.8	4,171.7	4,157.2	4,157.2
Equity — Owners of Parent	3,595.5	4,217.4	4,202.9	4,202.9
Total Equity	3,595.5	4,217.4	4,202.9	4,202.9
Liabilities
+ Provisions — Non-current	32.3	56.6	48.1	48.1
Non-current Liabilities	86.7	124.2	91.5	91.5
+ Borrowings — Current	2.5	2.5	2.5	2.5
+ Trade Payables	5.5	—	—	—
+ Other Current Financial Liab	37.5	—	—	—
+ Provisions — Current	45.0	51.3	30.3	30.3
+ Current Tax Liabilities	160.1	221.0	232.0	232.0
+ Other Current Liabilities	97.6	64.8	45.6	45.6
Current Liabilities	546.6	569.5	627.5	627.5
Total Liabilities	633.2	693.7	719.0	719.0
Total Equity & Liabilities	4,228.8	4,911.1	4,921.9	4,921.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.